malaria News
-
Global health action conference to focus on how to turn strategies, program ideas into practical action
How to make big strategies and specific program ideas work will be the focus of a rare cross-sector mix of senior executives and program implementers at the Global Health Action conference in Washington June 7-8. In addition, the conference will emphasize funding and partnership opportunities, both public-private and innovative 'collective actions,' which include collaboration among multiple ...
-
World Malaria Day 2015
On April 25th people across the globe take part in a wide range of activities to mark World Malaria Day. For half the world every day is malaria day - a day to keep up the fight against this killer disease. The World Malaria Day theme from 2013 – 2015 is ‘Invest in the future, defeat malaria’. The theme provides a common platform for countries to showcase their successes in ...
-
Stopping Malaria at Its Source - Without Drugs
TROY, New York, August 29, 2007 (ENS) - Malaria kills over one million people around the world, mostly young children. And the problem is growing as the Earth heats up due to global warming. Outbreaks of the deadly parasitic disease are spreading into temperate latitudes a little more each year, health officials report. Now an international team led by researchers from Rensselaer Polytechnic ...
-
Amivas (US), LLC Announces FDA Approval of Artesunate for Injection for Treatment of Severe Malaria
Artesunate for Injection 110 mg, powder and solvent for solution is approved by FDA for initial treatment of severe malaria in adult and pediatric patients. Artesunate for Injection is in a group of drugs known as “artemisinin derivatives” and is on the World Health Organization Model List of Essential Medicines. Since 2007, Investigational Intravenous (IV) Artesunate has been ...
-
Leaders at UN launch campaign to virtually eliminate malaria deaths by 2015
Government, business and civil society leaders gathered at the United Nations last week to launch a global campaign to reduce malaria deaths, currently at more than 1 million each year, to near zero by 2015, with an initial commitment of nearly a US$3bn. The Global Malaria Action Plan (GMAP) aims to cuts deaths and illness by 2010 to half their 2000 levels by scaling up access to ...
-
GM fungus `could be powerful weapon against malaria`
Infecting mosquitoes with a transgenic fungus could drastically cut their ability to transmit malaria, according to research published today in Science (25 February). Existing efforts to develop fungal malaria control focus on slowly killing mosquitoes before they have the chance to pass on Plasmodium, the malaria parasite. But they rely on mosquitoes being inoculated with parasitic fungus soon ...
By SciDev.Net
-
Manus Bio receives additional funding to fight malaria through biotechnology
Manus Bio, the leading biomanufacturer of natural products, has received a fourth award from the Bill & Melinda Gates Foundation to develop a scalable production route for the potential antimalarial drug, artemisinin. The $2 million award will enable Manus Bio to begin scaling up the unique biological process it has developed towards the key chemical intermediate, dihydroartemisinic acid. ...
By Manus Bio
-
Cuba launches next phase of African malaria project
Cuba has announced plans to build biolarvicide factories in Brazil and several African countries in a bid to tackle malaria and dengue fever. Biolarvicides are biological products that are added to water to kill mosquitoes at the larval stage. Labiofam — the Cuban laboratory in charge of the project — has been producing two biolarvicides, Bactivec and Griselesf, since the 1990s. The ...
By SciDev.Net
-
Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the pre-print publication of data from a Phase 2b clinical trial in children demonstrating 77 percent efficacy for a malaria vaccine candidate, R21, created by the University of Oxford that includes Novavax' Matrix-M™ adjuvant and is licensed to Serum ...
By Novavax
-
Zika - Malaria - Dengue viruses
Mosquitoes bring a large number of serious Krankeiten to people. Our ex-mosquito product acts biologically and environmentally compatible at all stages of mosquitoes. Other creatures are not harmed. The output is via standard spray systems and can therefore be used on all surfaces quickly and inexpensively. the more time is very fast and creates for months remedy the annoying insects. With ...
-
Amivas (US), LLC Announces U.S. Launch of Artesunate for Injection for Initial Treatment of Severe Malaria
Artesunate for Injection 110 mg, powder and solvent for solution is launching in the U.S. for initial treatment of severe malaria in adult and pediatric patients. From 2007 until today, the product was available in the U.S. only through an expanded access investigational new drug (IND) program managed by the Centers for Disease Control and Prevention (CDC). Amivas (US), LLC is now the sole ...
-
Biodiversity may help to prevent malaria outbreaks
Biodiversity could play a key role in preventing future outbreaks of malaria in tropical forests, according to a new study. Results indicate that a greater number of mosquito species could increase competition for mosquitoes that spread malarial parasites, whilst more vertebrate species could increase the likelihood that malarial parasites end up in ‘dead-end hosts’ that are unable to ...
-
Potential new vaccine candidate aims to block transmission of malaria parasites
The Jenner Institute at Oxford University, together with partners Imaxio and GSK, has started a phase I clinical trial of a novel vaccine candidate aimed at blocking transmission of malaria. Around half the world’s population is at risk of malaria and the disease led to an estimated 584,000 deaths in 2013. MosquirixTM, a malaria vaccine candidate developed by GSK, has just received a ...
By IMAXIO S.A.
-
Bestnet Europe Ltd. donates Netprotect(R) LLINs in support of the JCI nothing but nets Campaign
Bestnet Europe Ltd. has announced a donation of 2600 Netprotect Long Lasting Insecticide Incorporated Mosquito Nets (LLINs) to JCI (Junior Chamber International) to support their participation in the Budapest-Bamako Great African Run, the world's largest charity rally. JCI and the JCI Nothing But Nets campaign will hit the ground running in 2011 with the Budapest-Bamako Great African Run. The ...
-
Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria
Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced the publication of data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria. The research, conducted in collaboration with the University of Washington, was published in the peer-reviewed journal, Nature Partner ...
-
Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis
The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule therapies in collaboration with the foundation’s global network Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today $2.3M in grant ...
-
African officials agree to reduce environmental threats to health
African health and environment ministers attending a United Nations-sponsored conference which concluded this week in Gabon have agreed to form an alliance to try to reduce environmental threats to human health and well-being. The Libreville Declaration, named after the Gabonese capital where the four-day conference was held, commits governments in the region to take measures to stimulate the ...
-
Second biggest killer of under-fives being ignored
The international health agenda is failing to save the lives of millions of children by not responding appropriately to causes of child deaths, according to a new WaterAid report released this week. Hard-hitting figures published in the report reveal that the aid system is not responding rationally to disease burden. Despite diarrhoea being the second biggest killer of children, critical ...
By WaterAid
-
Global CSR forum on health held in Washington, D.C. with Booz Allen Hamilton, Pfizer HealthPoint services, and NGO partners
The U.S. Chamber Business Civic Leadership Center (BCLC) will host Global CSR Issue Forum: HEALTH on Monday, November 22, 2010, in Washington, DC. This is the fourth and final segment of the 2010 series focused on best practices and promising solutions in global CSR partnerships. Monday's event will showcase companies and NGO partners with integrated approaches to healthcare access and ...
-
Governments agree to reduce use of persistent chemicals (POPs)
Government delegates to the United Nations' Stockholm Convention on persistent organic pollutants (POPs) have added nine new chemicals to its list of substances that governments must control. Environmental NGOs have welcomed the move but are disappointed by the inadequacy and inconsistency of control measures approved for three the listed chemicals. Delegates at the meeting, held in Geneva in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you